• Facebook
  • Twitter
  • Youtube
  • Instagram
  • LinkedIn
  • Rss
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Your generous year-end donation will be matched $1 for $1    DONATE

Incremental Improvements Are Not Enough

October 1, 2014/in Cancer News, Cancer Policy Blog Care Planning, Palliative Care, Quality Cancer Care, Survivorship Care NCCS News /by actualize

Two years ago, the world lost an extraordinary person, my dear friend Dr. Brent Whitworth. He was a few days shy of his 42nd birthday when he learned of his diagnosis – stage IV kidney cancer – and he was devastated. He had surgery at a major cancer hospital and then entered a clinical trial for an oral chemotherapy drug. He responded well to treatment at first, but then the cancer grew. He lived for 19 months after his diagnosis, which is probably longer than he was expected to live. The medicine he took was rejected by the Food and Drug Administration (FDA) last year, a year after he died, because it had lower survival rates than the other possible treatments for kidney cancer. But it likely helped him to some degree.

I hear a lot of talk about the importance of “incremental improvements” in drug development, particularly for cancer – in other words, new drugs that provide relatively small improvements in survival over existing treatment options. I am not an expert on these arguments, and I’m not here to debate them. But I would like to put a human face on why incremental improvements are not enough.

Dr. Brent Whitworth
Dr. Brent Whitworth

One argument is that patients can string together different treatments, each of which may provide some number of months of response, to have a longer cumulative benefit. That may be true for some patients, but for others, like Brent, there is no opportunity for a second line of treatment. He was too weakened and debilitated by the treatment and the spread of the cancer to try another drug option.

I hear some patients say that they hope a drug will help them live long enough for the next advance that will give them more time. That works for some patients, in some diseases where the current treatments provide a long-term response. While the FDA has been approving drugs efficiently with new regulatory pathways, and in some cases the time to approval for new drugs is getting shorter, it’s still a long enough timeframe that small improvements in survival may not be enough to get to the “next big thing.”

Another argument is that treatments can help patients reach a certain milestone in their lives – attending a child’s graduation or wedding, being present for the birth of a grandchild, etc. A treatment that helps patients achieve an important life goal is important. But we have to remember that while someone may be grateful for the opportunity to enjoy these important life events, in the end what patients really want is to be cured or to have a long-term, manageable disease with a high quality of life. While some individuals with cancer may choose to accept the toxicities of cancer drugs for the hope of additional time, others choose less aggressive treatment and higher quality of life.

Brent left a successful business career to go to medical school. He knew that his calling was to be a doctor and care for patients. Being a doctor meant the world to him. He was brilliant and compassionate and thorough. He took the time to get to know his patients, understand their concerns, and get to the bottom of issues that may have gone undiagnosed previously. While he built a successful medical practice, he ensured that he had the time to devote to his patients.  Being a doctor was more than just a job to Brent, and it was about more than just science. It was a labor of love. One of his patients said about him, “The time, care and concern you showed each of us made all of us feel like friends, not just patients.  That is a gift you have, to make everyone feel special.”

When he was sick, he had to sell his medical practice, which was one of the hardest things he had ever done. He lost not only his livelihood but his identify as a physician and caregiver. He knew that when he was able to return to taking care of patients, he would be an even better doctor. Being a cancer patient had given him a new understanding of what it was like to be sick and place your trust in someone else to care for you. Unfortunately, Brent was never able to return to medicine.

In the 19 months he lived with cancer, he had some wonderful experiences – he found a church community and grew in his faith, he built and tended an amazing garden, he traveled with his partner and spent time with his family and friends. He was grateful for the time that he had.

But he would have much rather had more time and better quality of life. While I acknowledge that the pace of discovery can be slow and that incremental improvements are sometimes all we have, we can’t get complacent and celebrate, or even settle for, small improvements.

 

Post by NCCS CEO Shelley Fuld Nasso. Follow Shelley on Twitter @sfuldnasso.

Tags: cancer care, Cancer Survivorship, care planning, end of life, FDA, hospice, kidney cancer, Palliative Care, patient first, patient tools, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
0 0 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2014-10-01 12:47:022014-10-01 12:47:02Incremental Improvements Are Not Enough

Latest News

NCCS Advocates for Access to DIEP Flap Breast Reconstruction Surgery

March 10, 2023
The National Coalition for Cancer Survivorship recently joined the Community Breast Reconstruction Alliance (CBRA), a group of patient…
Read more
https://canceradvocacy.org/wp-content/uploads/Diane-Heditsian-PBS-Newshour-DIEP-Flap.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-03-10 13:24:422023-03-10 13:28:53NCCS Advocates for Access to DIEP Flap Breast Reconstruction Surgery
NCCS Advocate Spotlight: Betsy Glosik, A Cancer Survivor's Journey Through Integrative Healing and Advocacy

Betsy Glosik: A Cancer Survivor’s Journey Towards Integrative Healing and Advocacy

March 8, 2023
For Betsy Glosik, the early 2000s brought one trauma after another. She lost her aunt to melanoma. Then, tragically she lost her 20-yr old daughter to a car accident. In 2003, after years of mentioning her concerns about a mole on her foot to her dermatologist, and repeatedly having her concerns dismissed, Betsy was diagnosed with melanoma...
Read more
https://canceradvocacy.org/wp-content/uploads/Betsy-Glosik-Advocate-Spotlight-Blog-Banner.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-03-08 12:55:132023-03-08 12:55:13Betsy Glosik: A Cancer Survivor’s Journey Towards Integrative Healing and Advocacy

Webinar – Implementing the ASCO Guidelines for Exercise, Nutrition, and Weight Management with Your Patients and Practice

March 3, 2023
The National Coalition for Cancer Survivorship (NCCS) hosted a Survivorship Champions webinar discussing the American Society for Clinical…
Read more
https://canceradvocacy.org/wp-content/uploads/Implementing-ASCO-Guidelines-Webinar-Post-web.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2023-03-03 12:40:302023-03-03 12:42:40Webinar – Implementing the ASCO Guidelines for Exercise, Nutrition, and Weight Management with Your Patients and Practice

Take Action

Make An Impact

We are relentless in improving the quality of care and life after a cancer diagnosis. Your support makes all the difference right now.

Make a Gift »

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • This field is for validation purposes and should be left unchanged.

  • About
    • Our Mission
    • Our History
    • The 1986 Club
    • Our Team
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2022 State of Cancer Survivorship Survey
    • 2021 State of Cancer Survivorship Survey
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Survivorship Champions
    • Subscribe to NCCS Updates
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State-Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • 2022 Winners
      • Awardees
      • Reception and Sponsorship
    • Cancer Policy Roundtable (CPR)
      • Fall 2022 CPR
      • Spring 2022 CPR
      • Fall 2021 CPR
      • Spring 2021 CPR
      • Fall 2020 CPR
      • Spring 2020 CPR
    • Cancer Policy and Advocacy Team (CPAT) Virtual Symposium 2022
    • 2022 State of Survivorship Survey Results
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2023 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

WCOE: Over-Diagnosis, Over-Treatment, and a Broader View of Health NCCS Starburst Thumbnail NCCS Starburst Thumbnail WCOE: The Open Payments Data Release
Scroll to top
Download the Survey Report

"*" indicates required fields

Fill out the form below, and we’ll send the survey report, detailed presentation, and infographic to your email.
Name*
I am a...*
Select any/all that apply.
Consent*
By downloading the survey materials, you will receive updates and information from NCCS via email, which you may unsubscribe from at any time. Your information will never be sold to any third parties.
This field is for validation purposes and should be left unchanged.

Get Updates From NCCS

Be the first to hear about cancer policy and survivorship issues! Subscribe and receive the biweekly NCCS Health Care Roundup, invites to webinars and events, and more.

  • This field is for validation purposes and should be left unchanged.

Connect With Us

Twitter     Facebook     Instagram     LinkedIn     YouTube

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute